Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma

Urol Clin North Am. 2018 May;45(2):257-266. doi: 10.1016/j.ucl.2017.12.010. Epub 2018 Feb 21.

Authors

Tala Achkar¹, Rahul A Parikh²

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, 5150 Centre Avenue, Pittsburgh, PA 15232, USA.
² Department of Medicine, Division of Medical Oncology, University of Kansas Medical Center, 2330 Shawnee Mission Parkway, Suite 210, MS 5003, Westwood, KS 66205, USA. Electronic address: rparikh2@kumc.edu.

PMID: 29650141
DOI: 10.1016/j.ucl.2017.12.010

Abstract

This article summarizes the role of adjuvant chemotherapy in muscle-invasive and transitional cell carcinoma of the bladder and upper urinary tract.

Keywords: Adjuvant chemotherapy; Micrometastases; Muscle-invasive bladder cancer (MIBC); Neoadjuvant chemotherapy; Urothelial cancer.

Copyright © 2018 Elsevier Inc. All rights reserved.

Publication types

Review

MeSH terms

Carcinoma, Transitional Cell / pathology
Carcinoma, Transitional Cell / therapy*
Chemotherapy, Adjuvant
Combined Modality Therapy / methods*
Cystectomy
Humans
Immunotherapy
Kidney Neoplasms / therapy*
Neoadjuvant Therapy
Nephroureterectomy
Radiotherapy, Adjuvant
Ureteral Neoplasms / therapy*
Urinary Bladder Neoplasms / pathology
Urinary Bladder Neoplasms / therapy*